SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Caliper Technologies - CALP
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (109)10/3/2007 1:31:47 PM
From: Steve Lokness   of 114
 
Tuck;

Of course, CALP is just kind of sitting there, share price-wise. One does wonder how XGEN would have done independently. I'd guess a little better than CALP has in that time frame.

Ya, I suspect you are right. But then again, that suggest CALP did a wise buy? The news this morning is not much and my gut says it will be followed by something else. Not sure what. Someone on Yahoo answered your question on the lawsuit; the judge sent them back into their corners to prepare better - according to the post. (The link for this ruling is 64 pages long). If Anticancer wasn't prepared enough - my guess is that there is an agreement before they come back?

And this from your post;
More than 70% of major pharmaceutical companies, and 60% of major biotech companies, now hold a license to the Caliper Optical Imaging Patent Suite, and smaller biotechs are following suit in increasing numbers."

This has to be worth something in some way or another I would think. No?

Good Investing;
steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News